DDCM:基于支持向量回归算法的药物重新定位的计算策略
Manyi Xu1, Wan Li1, Jiaheng He1
1College of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150000, China.
International journal of molecular sciences
|May 25, 2024
概括
这项研究引入了一种使用支持向量回归 (SVR) 的新型疾病药物相关性方法 (DDCM),用于识别潜在的新生病和心血管疾病等疾病的药物. 该方法有效地预测和验证治疗候选药物,为药物重新定位提供了一种新的方法.
科学领域:
- 计算生物学是一种计算生物学.
- 药理学 药理学是指药理学的学科.
- 生物信息学是一种生物信息学.
背景情况:
- 药物重新定位通过确定现有药物的新用途来加速药物开发.
- 越来越多的生物数据需要先进的计算方法来有效地发现药物.
- 鉴定复杂疾病的潜在治疗药物仍然是一个重大挑战.
研究的目的:
- 提出一种新的计算方法,即疾病药物相关性方法 (DDCM),用于预测潜在的治疗药物.
- 整合多来源和多层次的生物数据,以提高药物重新定位的准确性.
- 为了确定潜在的治疗药物治疗瘤和心血管疾病.
主要方法:
- 开发了一种综合多种生物数据的疾病药物相关性方法 (DDCM).
- 利用支持向量回归 (SVR) 预测疾病与药物相关性.
- 构建了一个混合相似性矩阵,并使用随机扰动和逐步选管道.
主要成果:
- 成功预测了瘤和心血管疾病的潜在治疗药物.
- 通过文献,功能,药物标和生存必需基因验证预测药物的治疗潜力.
- 通过将结果与经典方法进行比较,并进行共用药物分析来证明该方法的可行性.
结论:
- 通过利用综合生物数据,DDCM为药物重新定位提供了合理有效的方法.
- 该方法为了解疾病-药物相关性和疾病病原发生提供了一个新的视角.
- 经过验证的预测强调了DDCM在加速新治疗剂的发现方面的潜力.
相关概念视频
Structure-Activity Relationships and Drug Design
699
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
699
Drug Discovery: Overview
7.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.8K
Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving
50
Mechanistic models play a crucial role in algorithms for numerical problem-solving, particularly in nonlinear mixed effects modeling (NMEM). These models aim to minimize specific objective functions by evaluating various parameter estimates, leading to the development of systematic algorithms. In some cases, linearization techniques approximate the model using linear equations.
In individual population analyses, different algorithms are employed, such as Cauchy's method, which uses a...
In individual population analyses, different algorithms are employed, such as Cauchy's method, which uses a...
50
Quantitative Aspects of Drug-Receptor Interaction
973
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
973
Analysis of Population Pharmacokinetic Data
252
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
252
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
68
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
68


